The quantification of Bax.Bcl2 ratio for AMP-001 (Fig 5) clearly indicates that a time and dose dependent effect in MDA-MB-231 cancer cells treated with AMP-001 is greater than 1.00, while alpha-tocopherol (a negative control) shows no significant variation. Here, BAX is linked to cancer.